BNY Mellon Small/Mid Cap Growth Fund Q4 2024 Commentary
The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 7.34%% during the fourth quarter of 2024. Click here to read the full commentary.
Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Class Action Against TransMedics Group, Inc. (TMDX)
If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected].
TMDX SHAREHOLDER NOTICE: TransMedics Group, Inc. Investors are Reminded to Contact BFA Law before the April 15 Class Action Deadline
New York, New York-- (Newsfile Corp. - March 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Le Lézard1d
Shareholders that lost money on TransMedics Group, Inc.(TMDX) should contact The Gross Law Firm about pending Class Action - TMDX
The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...
Canaccord Genuity Group Reiterates “Buy” Rating for TransMedics Group (NASDAQ:TMDX)
TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...
Le Lézard2d
Investors who lost money on TransMedics Group, Inc.(TMDX) should contact Levi & Korsinsky about pending Class Action - TMDX
Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") of a class action securities ...
Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The company's warm perfusion devices are ...
TMDX CLASS ACTION ALERT: Transmedics Group, Inc. Is Being Sued In Connection With Its Business Practices – Contact Robbins LLP For Information
On this news, the price of TransMedics stock fell $3.74 per share, or 5.15%, to close at $68.81 on January 10, 2025. On January 13, 2025, TransMedics stock fell a further $4.76 per share, or 6.9%, to ...
AHA/ASA Journals7d
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated ...
A Closer Look At TransMedics Group's Earnings
NasdaqGM:TMDX Earnings and Revenue History March 7th 2025 A Closer Look At TransMedics Group's Earnings. One key financial ratio used to measure how well a company converts its pr ...
The Bakersfield Californian9d
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, ...
William Blair Lifts Earnings Estimates for TransMedics Group
Equities research analysts at William Blair raised their Q3 2025 earnings estimates for shares of TransMedics Group in a ...